These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 12374692

  • 1. Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen.
    Kobayashi H, Omiya R, Ruiz M, Huarte E, Sarobe P, Lasarte JJ, Herraiz M, Sangro B, Prieto J, Borras-Cuesta F, Celis E.
    Clin Cancer Res; 2002 Oct; 8(10):3219-25. PubMed ID: 12374692
    [Abstract] [Full Text] [Related]

  • 2. Identification of helper T-cell epitopes that encompass or lie proximal to cytotoxic T-cell epitopes in the gp100 melanoma tumor antigen.
    Kobayashi H, Lu J, Celis E.
    Cancer Res; 2001 Oct 15; 61(20):7577-84. PubMed ID: 11606397
    [Abstract] [Full Text] [Related]

  • 3. Identification of a MHC class-II restricted epitope in carcinoembryonic antigen.
    Shen L, Schroers R, Hammer J, Huang XF, Chen SY.
    Cancer Immunol Immunother; 2004 May 15; 53(5):391-403. PubMed ID: 14624313
    [Abstract] [Full Text] [Related]

  • 4. Tumor-reactive T helper lymphocytes recognize a promiscuous MAGE-A3 epitope presented by various major histocompatibility complex class II alleles.
    Kobayashi H, Song Y, Hoon DS, Appella E, Celis E.
    Cancer Res; 2001 Jun 15; 61(12):4773-8. PubMed ID: 11406551
    [Abstract] [Full Text] [Related]

  • 5. Use of two predictive algorithms of the world wide web for the identification of tumor-reactive T-cell epitopes.
    Lu J, Celis E.
    Cancer Res; 2000 Sep 15; 60(18):5223-7. PubMed ID: 11016651
    [Abstract] [Full Text] [Related]

  • 6. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
    Kobayashi H, Nagato T, Takahara M, Sato K, Kimura S, Aoki N, Azumi M, Tateno M, Harabuchi Y, Celis E.
    Cancer Res; 2008 Feb 01; 68(3):901-8. PubMed ID: 18245493
    [Abstract] [Full Text] [Related]

  • 7. Identification of HLA DR7-restricted epitopes from human telomerase reverse transcriptase recognized by CD4+ T-helper cells.
    Schroers R, Huang XF, Hammer J, Zhang J, Chen SY.
    Cancer Res; 2002 May 01; 62(9):2600-5. PubMed ID: 11980655
    [Abstract] [Full Text] [Related]

  • 8. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A, Chatterjee SK, Foon KA, Celis E, Bhattacharya-Chatterjee M.
    Cancer Res; 2007 Mar 15; 67(6):2881-92. PubMed ID: 17363612
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CD4(+) T cells from healthy subjects and colon cancer patients recognize a carcinoembryonic antigen-specific immunodominant epitope.
    Campi G, Crosti M, Consogno G, Facchinetti V, Conti-Fine BM, Longhi R, Casorati G, Dellabona P, Protti MP.
    Cancer Res; 2003 Dec 01; 63(23):8481-6. PubMed ID: 14679013
    [Abstract] [Full Text] [Related]

  • 12. Defining promiscuous MHC class II helper T-cell epitopes for the HER2/neu tumor antigen.
    Kobayashi H, Wood M, Song Y, Appella E, Celis E.
    Cancer Res; 2000 Sep 15; 60(18):5228-36. PubMed ID: 11016652
    [Abstract] [Full Text] [Related]

  • 13. Identification and characterization of a T-helper peptide from carcinoembryonic antigen.
    Ruiz M, Kobayashi H, Lasarte JJ, Prieto J, Borrás-Cuesta F, Celis E, Sarobe P.
    Clin Cancer Res; 2004 Apr 15; 10(8):2860-7. PubMed ID: 15102695
    [Abstract] [Full Text] [Related]

  • 14. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.
    Zaremba S, Barzaga E, Zhu M, Soares N, Tsang KY, Schlom J.
    Cancer Res; 1997 Oct 15; 57(20):4570-7. PubMed ID: 9377571
    [Abstract] [Full Text] [Related]

  • 15. Defining MHC class II T helper epitopes for WT1 tumor antigen.
    Kobayashi H, Nagato T, Aoki N, Sato K, Kimura S, Tateno M, Celis E.
    Cancer Immunol Immunother; 2006 Jul 15; 55(7):850-60. PubMed ID: 16220325
    [Abstract] [Full Text] [Related]

  • 16. Identification of a promiscuous HLA DR-restricted T-cell epitope derived from the inhibitor of apoptosis protein survivin.
    Piesche M, Hildebrandt Y, Zettl F, Chapuy B, Schmitz M, Wulf G, Trümper L, Schroers R.
    Hum Immunol; 2007 Jul 15; 68(7):572-6. PubMed ID: 17584578
    [Abstract] [Full Text] [Related]

  • 17. Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells.
    Kawashima I, Tsai V, Southwood S, Takesako K, Sette A, Celis E.
    Cancer Res; 1999 Jan 15; 59(2):431-5. PubMed ID: 9927058
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.